Dana dhuwit diétung saben saham Bausch Health Corp (BHC)

Simbol lan logo merek Bausch Health Corp (BHC)

Bausch Health Companies (BHC) is implementing environmental standards and bioethics into pharmaceutical production. The annual trend of cash per share allows for an assessment of the liquidity vector, with the 6.70 mark reflecting the latest data. Brand loyalty to Bausch + Lomb supports the holding's position, while debt restructuring and an advanced distribution network for branded generics ensure a stable operating margin.

Dhuwit awis saben saham: Bausch Health Companies Inc. (BHC) kanggo 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis Bausch Health (BHC)

- rega lan prakiraan konsensus rega:
- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:BHC (Valeant Pharmaceuticals)
Barang unggulan bauschhealth.com

Bausch Health Companies (BHC) vulnerability to patent disputes over Xifaxan and its massive debt makes liquidity a critical factor for business survival. By analyzing cash per share trends, an investor assesses the specific volume of free cash flow that determines the company's ability to service obligations and withstand shocks, where an increase in this metric signals a lower default risk but may indicate inefficient capital allocation.